7,916 results on '"Dermal Fibrosis"'
Search Results
2. A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis
3. A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis.
4. C-X-C domain ligand 14-mediated stromal cell–macrophage interaction as a therapeutic target for hand dermal fibrosis
5. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
6. C-X-C domain ligand 14-mediated stromal cell–macrophage interaction as a therapeutic target for hand dermal fibrosis
7. Positive feedback loops between fibroblasts and the mechanical environment contribute to dermal fibrosis
8. EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis.
9. Epidermal Potentiation of Dermal Fibrosis: Lessons from Occlusion and Mucosal Healing
10. Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in Mice
11. IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation
12. The Role for miR-146b-5p in the Attenuation of Dermal Fibrosis and Angiogenesis by Targeting PDGFRα in Skin Wounds
13. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
14. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
15. A tension offloading patch mitigates dermal fibrosis induced by pro-fibrotic skin injections.
16. The Relationship between Time, Race, and Estrogen Receptor Alpha in Estradiol-Induced Dermal Fibrosis
17. Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis
18. Transient receptor potential vanilloid-3 (TRPV3) channel induces dermal fibrosis via the TRPV3/TSLP/Smad2/3 pathways in dermal fibroblasts
19. The Relationship between Time, Race, and Estrogen Receptor Alpha in Estradiol-Induced Dermal Fibrosis.
20. Intervention of Inflammatory Monocyte Activity Limits Dermal Fibrosis
21. Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650
22. Elucidating the cellular mechanism for E2-induced dermal fibrosis
23. Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis
24. Elucidating the cellular mechanism for E2-induced dermal fibrosis
25. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
26. Contribution of keratinocytes to dermal fibrosis
27. Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis
28. Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9 , 650.
29. Targeting Myofibroblasts in Dermal Fibrosis: A Retinoid Connection.
30. S100A12 Induced in the Epidermis by Reduced Hydration Activates Dermal Fibroblasts and Causes Dermal Fibrosis
31. Adipose tissue-derived stem cells ameliorates dermal fibrosis in a mouse model of scleroderma
32. Inhibition of Wnt signaling pathway suppresses radiation-induced dermal fibrosis
33. Immune cells and associated molecular markers in dermal fibrosis with focus on raised cutaneous scars.
34. Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis
35. Erratum to "STAT6 suppression prevents bleomycin-induced dermal fibrosis".
36. Simvastatin cream alleviates dermal fibrosis in a rabbit ear hypertrophic scar model.
37. Inhibition of Wnt signaling pathway suppresses radiation-induced dermal fibrosis
38. STAT6 suppression prevents bleomycin-induced dermal fibrosis.
39. FIZZ1-Induced Myofibroblast Transdifferentiation from Adipocytes and Its Potential Role in Dermal Fibrosis and Lipoatrophy
40. Localized Controlled Release of Kynurenic Acid Encapsulated in Synthetic Polymer Reduces Implant—Induced Dermal Fibrosis
41. Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis: The role of alternatively activated macrophages on the development of fibrosis
42. Overexpression of TNF-α-converting enzyme in fibroblasts augments dermal fibrosis after inflammation
43. Extracellular Generation of Adenosine by the Ectonucleotidases CD39 and CD73 Promotes Dermal Fibrosis
44. Proteasome Inhibition Prevents Development of Experimental Dermal Fibrosis
45. S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways
46. 769 System xCT as dermal fibrosis potentiator and new therapeutic target in systemic sclerosis
47. Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.
48. STAT6 suppression prevents bleomycin-induced dermal fibrosis.
49. Experimental models of dermal fibrosis and systemic sclerosis
50. Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.